ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $19,273,000 | +552.7% | 476,814 | +829.2% | 0.05% | +557.1% |
| Q2 2015 | $2,953,000 | -50.1% | 51,314 | -62.5% | 0.01% | -50.0% |
| Q1 2014 | $5,916,000 | -54.5% | 136,914 | -58.0% | 0.01% | -54.8% |
| Q4 2013 | $12,992,000 | +5.2% | 326,114 | -0.9% | 0.03% | +3.3% |
| Q3 2013 | $12,347,000 | +1546.3% | 328,914 | +1078.3% | 0.03% | +1400.0% |
| Q2 2013 | $750,000 | – | 27,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |